The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy

T-cell immunoreceptor with Ig and ITIM domains (TIGIT) is an inhibitory checkpoint receptor that negatively regulates Tcell responses. CD226 competes with TIGIT for binding to the CD155 ligand, delivering a positive signal to the T cell. Here we studied the expression of TIGIT and CD226 in a cohort...

詳細記述

書誌詳細

主要な著者:	Francesca Arruga, Marta Rubin, Despoina Papazoglou, Andrea Iannello, Nikolaos Ioannou, Riccardo Moia, Davide Rossi, Gianluca Gaidano, Marta Coscia, Luca Laurenti, Giovanni D’Arena, John N. Allan, Richard R. Furman, Tiziana Vaisitti, Alan G. Ramsay, Silvia Deaglio
フォーマット:	Artigo
言語:	Inglês
出版事項:	Ferrata Storti Foundation 2023-01-01
シリーズ:	Haematologica
オンライン･アクセス:	https://haematologica.org/article/view/10940
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!